Attached files

file filename
EX-10.56 - EXHIBIT 10.56 - BIOXYTRAN, INCsf0106h_ex10-56.htm
EX-32 - EXHIBIT 32 - BIOXYTRAN, INCsf0106h_ex32.htm
EX-31.2 - EXHIBIT 31.2 - BIOXYTRAN, INCsf0106h_ex31-2.htm
EX-31.1 - EXHIBIT 31.1 - BIOXYTRAN, INCsf0106h_ex31-1.htm
EX-21.3 - EXHIBIT 21.3 - BIOXYTRAN, INCsf0106h_ex21-3.htm
EX-10.57 - EXHIBIT 10.57 - BIOXYTRAN, INCsf0106h_ex10-57.htm
10-K - 10-K - BIOXYTRAN, INCsf0106h_10k.htm

Exhibit 23.1

 

To Whom It May Concern:

 

We hereby consent to the use in the annual report of Bioxytran, Inc., on Form 10K, filed on April 9, 2021, of our Report of Independent Registered Public Accounting Firm, dated April 9, 2021, on the consolidated balance sheet of Bioxytran, Inc., as at December 31, 2020 and the related statements of operations, changes in shareholders’ deficit and cash flows for the period ended December 31, 2020 and the related notes, which appear in the form 10K.

 

We also consent to the references to us under the headings “Experts” in such form 10K. 

 

/s/ Pinnacle Accountancy Group of Utah

 

 

 

Pinnacle Accountancy Group of Utah

Farmington, UT

April 9, 2021

 

58